Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 159
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of which...

Part 2: Can low carbohydrate ketogenic diets inhibit cancers?

We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...

Targeted Drug Delivery by using Magnetic Nanoparticles

What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

Backer Badge Funded